Sprint Bioscience AB - ESG Rating & Company Profile powered by AI
The assessment of Sprint Bioscience AB employs intelligence from across the web and also from public filings by Sprint Bioscience AB. The report of Sprint Bioscience AB was assembled by All Street Sevva using leading NLP. The page is a zero-cost Environmental, Social and Governance analysis for Sprint Bioscience AB.
Sprint Bioscience AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.7, social score of 6.4 and governance score of 2.7.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1443 | XSpray Pharma AB (publ) | 4.0 | High |
| 1443 | Zhong Yuan Bio-Technology Holdings Ltd | 4.0 | High |
| ... | ... | ... | |
| 1476 | Sprint Bioscience AB | 3.9 | Medium |
| 1476 | Anebulo Pharmaceuticals Inc | 3.9 | Medium |
| 1476 | Anhui Sunhere Pharmaceutical Excipients Co Ltd | 3.9 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sprint Bioscience AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sprint Bioscience AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Sprint Bioscience AB report the average age of the workforce?
Sign up for free to unlockDoes Sprint Bioscience AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sprint Bioscience AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sprint Bioscience AB disclose cybersecurity risks?
Sign up for free to unlockDoes Sprint Bioscience AB offer flexible work?
Sign up for free to unlockDoes Sprint Bioscience AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sprint Bioscience AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sprint Bioscience AB conduct supply chain audits?
Sign up for free to unlockDoes Sprint Bioscience AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sprint Bioscience AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sprint Bioscience AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sprint Bioscience AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sprint Bioscience AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sprint Bioscience AB disclose water use targets?
Sign up for free to unlockDoes Sprint Bioscience AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Sprint Bioscience AB have a product recall in the last two years?
Sign up for free to unlockDoes Sprint Bioscience AB disclose incidents of discrimination?
Sign up for free to unlockDoes Sprint Bioscience AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sprint Bioscience AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sprint Bioscience AB disclose parental leave metrics?
Sign up for free to unlockDoes Sprint Bioscience AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sprint Bioscience AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sprint Bioscience AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sprint Bioscience AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sprint Bioscience AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sprint Bioscience AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sprint Bioscience AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Sprint Bioscience AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sprint Bioscience AB disclose its waste policy?
Sign up for free to unlockDoes Sprint Bioscience AB report according to TCFD requirements?
Sign up for free to unlockDoes Sprint Bioscience AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sprint Bioscience AB disclose energy use targets?
Sign up for free to unlockDoes Sprint Bioscience AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sprint Bioscience AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sprint Bioscience AB
These potential risks are based on the size, segment and geographies of the company.
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.